Zoono Group Limited (AU:ZNO)
ASX:ZNO
Want to see AU:ZNO full AI Analyst Report?
ZNO Stock Chart & Stats
AU$0.08
<AU$0.01(8.00%)
At close: 4:00 PM EST
AU$0.08
<AU$0.01(8.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.18
Previous CloseN/A
Volume41.30K
Average Volume (3M)153.26K
Market Cap
AU$26.00M
Enterprise ValueAU$26.15M
Total Cash (Recent Filing)AU$475.33K
Total Debt (Recent Filing)AU$625.70K
Price to Earnings (P/E)―
Beta0.22
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding406,211,760
10 Day Avg. Volume257,173
30 Day Avg. Volume153,260
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.62
Price to Sales (P/S)9.30
P/FCF Ratio-6.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Manageable Solvency RiskLow reported leverage (debt-to-equity ~0.18 in FY2025) materially reduces near-term solvency pressure versus highly leveraged peers. This structural balance-sheet strength gives the company more flexibility to access working capital and negotiate credit while it works to restore operating profitability.
Exposure To Structural Hygiene/infection-prevention MarketModest FY2025 revenue growth and the company’s focus on long‑lasting antimicrobials position it within a durable, structural market—hygiene and infection prevention. Persistent demand from consumer and institutional channels supports a multi‑year growth runway if commercial execution and distribution scale are achieved.
Product Development And Manufacturing CapabilityOwning product development and manufacturing provides control over formulations, quality and potential IP protection for long‑lasting antimicrobials. Vertical capability supports differentiated product offerings and margin expansion opportunities if production efficiency and commercial scale are realized over time.
Bears Say
Deep And Persistent UnprofitabilityThe company’s deeply negative margins and recurring gross losses indicate a structurally unprofitable business model at current scale. Sustained negative profitability undermines reinvestment capacity and requires either dramatic margin improvement or consistent external funding to sustain operations beyond the medium term.
Chronic Negative Cash GenerationConsistently negative operating and free cash flow forces dependence on external financing, raising dilution and refinancing risk. Without durable positive cash generation, the firm faces limited runway to scale commercial efforts or absorb shocks, worsening long‑term viability absent turnaround.
Eroded Equity Base And Weak ReturnsSubstantial erosion of shareholders' equity over multiple years weakens the capital buffer and constrains ability to fund growth or withstand setbacks. A diminished equity base increases perceived risk for lenders and partners and reduces strategic optionality for long‑term investments or scaling initiatives.
Zoono Group Limited News
ZNO FAQ
What was Zoono Group Limited’s price range in the past 12 months?
Zoono Group Limited lowest share price was AU$0.03 and its highest was AU$0.18 in the past 12 months.
What is Zoono Group Limited’s market cap?
Zoono Group Limited’s market cap is AU$26.00M.
When is Zoono Group Limited’s upcoming earnings report date?
Zoono Group Limited’s upcoming earnings report date is Aug 20, 2026 which is in 62 days.
How were Zoono Group Limited’s earnings last quarter?
Zoono Group Limited released its earnings results on Feb 19, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is Zoono Group Limited overvalued?
According to Wall Street analysts Zoono Group Limited’s price is currently Overvalued.
Does Zoono Group Limited pay dividends?
Zoono Group Limited pays a Notavailable dividend of AU$0.03 which represents an annual dividend yield of N/A. See more information on Zoono Group Limited dividends here
What is Zoono Group Limited’s EPS estimate?
Zoono Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zoono Group Limited have?
Zoono Group Limited has 406,211,760 shares outstanding.
What happened to Zoono Group Limited’s price movement after its last earnings report?
Zoono Group Limited reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.515%.
Which hedge fund is a major shareholder of Zoono Group Limited?
Currently, no hedge funds are holding shares in AU:ZNO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zoono Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.18%
12-Months-Change
Fundamentals
Return on Equity
-108.90%
Trailing 12-Months
Asset Growth
-23.69%
Trailing 12-Months
Company Description
Zoono Group Limited
Zoono Group Limited, along with its associated entities, specializes in the innovation, development, and global distribution of a variety of antimicrobial solutions, catering to both the New Zealand market and international clientele. Their product line features items such as hand cleansers, specialized textile applications, mold remediation treatments, and surface disinfectants. Zoono provides its services to a broad spectrum of industries, including the aviation, medical, early education, facilities management, transportation, academic, and hospitality sectors. The firm was established in 1986 and maintains its principal operations from Auckland, New Zealand.
Technical Analysis
Skin Elements Limited
―
Food Revolution Group Ltd.
―
Fiji Kava Limited
―
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---